NBCB News Alert First Nbc Bank Holding Company (NBCB) 33.68 12/13/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
First Nbc Bank Holding Company (NBCB) 33.68 $NBCB

Citigroup Rises Higher on Revenue Growth & Streamlining - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 05, 4:00PM CST
On Nov 28, 2014, we issued an updated research report on Citigroup Inc. (C). The company exhibits decent fundamentals amid several ongoing issues. Shares of this major regional bank have recorded a year-to-date return of 5.6%.
CUBI: 18.17 (-0.18), C: 53.40 (-1.11), NBCB: 33.68 (-0.33), OZRK: 35.25 (-0.33)

Wells Fargo (WFC) Rises on Organic Growth: Should We Hold? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 6:20PM CST
On Nov 28, 2014, we issued an updated research report on Wells Fargo & Company (WFC). Shares of this major regional bank have recorded a year-to-date return of 23.8%.
CUBI: 18.17 (-0.18), WFC: 53.70 (-0.73), NBCB: 33.68 (-0.33), OZRK: 35.25 (-0.33)

First NBC Bank beats by $0.05, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 4:56PM CDT

NBCB: 33.68 (-0.33)

First NBC Bank Holding Company Announces 2014 Third Quarter Results
GlobeNewswire - Tue Oct 28, 4:38PM CDT
First NBC Bank Holding Company (Nasdaq:NBCB), the holding company for First NBC Bank ("Company" , today announced financial results for the third quarter of 2014. For the quarter ended September 30, 2014, the Company reported net income available to common shareholders of $14.0 million, or $0.75 per share, as compared to $12.4 million, or $0.67 per share, for the second quarter of 2014, and $9.9 million, or $0.55 per share, for the third quarter of 2013. The Company's earnings per share on a diluted basis were $0.73, $0.65, and $0.54 per diluted share, for the third quarter of 2014, second quarter of 2014, and third quarter of 2013, respectively. The effect on diluted earnings per share was an increase of $0.08 per diluted share, or 12.3%, over the second quarter of 2014, and an increase of $0.19 per diluted share, or 35.2%, over the third quarter of 2013.
NBCB: 33.68 (-0.33)

Iberiabank (IBKC) Set to Acquire Florida Bank Group - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 3:55PM CDT
Iberiabank (IBKC) and Florida Bank Group has entered into a definitive agreement wherein Iberiabank will acquire Florida Bank Group via a merger.
FCBC: 15.60 (-0.20), IBKC: 62.12 (-1.08), SFNC: 39.05 (-1.05), NBCB: 33.68 (-0.33)

Ladenburg Thalmann Hits 52-Week High on Acquisition Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 10:30AM CDT
Despite the strong price appreciation, Ladenburg Thalmann has plenty of upside left, given the estimate revisions witnessed over the last 60 days.
SFNC: 39.05 (-1.05), AI: 26.96 (-0.54), LTS: 3.75 (-0.08), NBCB: 33.68 (-0.33)

Simmons First National Up to Strong Buy on Growth Initiative - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 9:40AM CDT
On Oct 4, Zacks Investment Research upgraded Simmons First National Corporation (SFNC) to a Zacks Rank #1 (Strong Buy).
FCBC: 15.60 (-0.20), SFNC: 39.05 (-1.05), NBCB: 33.68 (-0.33), FNB: 12.46 (-0.14)

Will BancorpSouth's Cost Control Surrender to Weak Deposits? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 10:10AM CDT
On Sep 25, 2014, we issued an updated research report on BancorpSouth (BXS).
LION: 15.69 (-0.13), BXS: 21.41 (+0.10), CFNL: 18.81 (unch), NBCB: 33.68 (-0.33)

Northern Trust Offers Improved IAS19 Solution to Clients - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 01, 10:15AM CDT
Northern Trust (NTRS) revealed an enhanced reporting solution for the pension fund clients to fulfil the International Accounting Standard 19 (IAS19) requirements as stated under the International Financial Reporting Standards (IFRS).
LION: 15.69 (-0.13), NTRS: 65.90 (-0.96), NRIM: 27.38 (-0.71), NBCB: 33.68 (-0.33)

Will Northern Trust Gain from T2S Strategy Implementation? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 29, 5:30PM CDT
Northern Trust (NTRS) announced the implementation of Target2-Securities (T2S) strategy to provide better services to its clients in the form of improved liquidity as well as asset safety.
AB: 24.24 (-0.98), NTRS: 65.90 (-0.96), DB: 30.78 (-0.56), NBCB: 33.68 (-0.33)

Comerica's Cost Control on Track; Should You Stay Invested? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 3:55PM CDT
On Sep 1, 2014, we issued an updated research report on Comerica Inc. (CMA).
RCAP: 11.81 (-0.10), FCBC: 15.60 (-0.20), NBCB: 33.68 (-0.33), CMA: 44.37 (-1.52)

Citi Settles OFAC Sanctions Violations for $217,841 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 4:35PM CDT
Citigroup Inc. (C) has reached a settlement to resolve the issue of violating multiple sanctions programs of the Office of Foreign Assets Control (OFAC).
RCAP: 11.81 (-0.10), FCBC: 15.60 (-0.20), C: 53.40 (-1.11), NBCB: 33.68 (-0.33)

First NBC Bank Up to Strong Buy on Q2 Earnings Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 03, 6:15PM CDT
On Aug 28, Zacks Investment Research upgraded First NBC Bank Holding Company (NBCB) to a Zacks Rank #1 (Strong Buy).
FCBC: 15.60 (-0.20), FFKT: 22.65 (-0.31), NBCB: 33.68 (-0.33), OZRK: 35.25 (-0.33)

Why First NBC Bank (NBCB) Stock Might be a Great Pick - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 7:50AM CDT
First NBC Bank is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
NBCB: 33.68 (-0.33)

U.S. Banks Stay Afloat - Cutting Costs or Core Business? - Industry Outlook
Kalyan Nandy - Zacks Investment Research - Tue Aug 05, 4:51AM CDT
U.S. Banks Stay Afloat - Cutting Costs or Core Business? - Industry Outlook
BXS: 21.41 (+0.10), BOKF: 58.67 (-1.75), HBAN: 10.06 (-0.19), FRC: 50.21 (-0.79), CVCY: 11.00 (-0.27), UBNK: 13.92 (-0.07), NBCB: 33.68 (-0.33), OZRK: 35.25 (-0.33), FMER: 18.09 (-0.09), CFR: 70.00 (-1.62), LION: 15.69 (-0.13), BANC: 10.60 (-0.19), TCBK: 24.80 (-0.61), TSC: 10.20 (-0.12), DNBF: 21.72 (+0.54), FCBC: 15.60 (-0.20), OLBK: 15.27 (-0.18), AROW: 26.25 (-0.04), FFKT: 22.65 (-0.31), HBNC: 24.70 (-0.14), CTBI: 35.86 (-0.17), CSFL: 10.97 (-0.22), FBP: 5.53 (-0.03), CYN: 77.75 (-0.63), TCBI: 52.84 (-1.24), TCFC: 20.03 (-0.15), CBU: 36.86 (-0.69), FULT: 11.87 (-0.03), MOFG: 27.70 (-0.76)

U.S. Banks Stay Afloat - Cutting Costs or Core Business? - Zacks Analyst Interviews
Kalyan Nandy - Zacks Investment Research - Tue Aug 05, 4:51AM CDT
U.S. Banks Stay Afloat - Cutting Costs or Core Business? - Zacks Analyst Interviews
BXS: 21.41 (+0.10), BOKF: 58.67 (-1.75), HBAN: 10.06 (-0.19), FRC: 50.21 (-0.79), CVCY: 11.00 (-0.27), UBNK: 13.92 (-0.07), NBCB: 33.68 (-0.33), OZRK: 35.25 (-0.33), FMER: 18.09 (-0.09), CFR: 70.00 (-1.62), LION: 15.69 (-0.13), BANC: 10.60 (-0.19), TCBK: 24.80 (-0.61), TSC: 10.20 (-0.12), DNBF: 21.72 (+0.54), FCBC: 15.60 (-0.20), OLBK: 15.27 (-0.18), AROW: 26.25 (-0.04), FFKT: 22.65 (-0.31), HBNC: 24.70 (-0.14), CTBI: 35.86 (-0.17), CSFL: 10.97 (-0.22), FBP: 5.53 (-0.03), CYN: 77.75 (-0.63), TCBI: 52.84 (-1.24), TCFC: 20.03 (-0.15), CBU: 36.86 (-0.69), FULT: 11.87 (-0.03), MOFG: 27.70 (-0.76)

First NBC Bank Holding Company Announces 2014 Second Quarter Results
GlobeNewswire - Mon Jul 28, 6:12AM CDT
First NBC Bank Holding Company (Nasdaq:NBCB), the holding company for First NBC Bank ("Company" , today announced financial results for the second quarter of 2014. For the quarter ended June 30, 2014, the Company reported net income available to common shareholders of $12.4 million, or $0.67 per share, as compared to $12.5 million, or $0.68 per share, for the first quarter of 2014, and $8.1 million, or $0.51 per share, for the second quarter of 2013. The Company's earnings per share on a diluted basis were $0.65, $0.66, and $0.49 per diluted share, for the second quarter of 2014, first quarter of 2014, and second quarter of 2013, respectively. This was a decrease of $0.01 per diluted share, or 1.1%, over the first quarter of 2014, and an increase of $0.16 per diluted share, or 31.6%, over the second quarter of 2013.
NBCB: 33.68 (-0.33)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 286

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 238

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 305

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 131

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 161

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 0

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 0

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Breakthroughs in Lung Cancer Treatment with Reqorsa

Updated Category News Views 182

Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...

Continue Reading
EfTEN United Property Fund Reports October Earnings and NAV

Updated Category News Views 192

Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...

Continue Reading
Cardiff Oncology Reports Encouraging Results in mCRC Trial

Updated Category News Views 236

Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...

Continue Reading
Japan's Growing Casting Polyurethane Market and Its Future

Updated Category News Views 127

Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...

Continue Reading
Hudson Technologies Faces Challenges Amid Downgrade by B.Riley

Updated Category News Views 353

B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...

Continue Reading